++
For further information, see CMDT Part 19-12: Preeclampsia-Eclampsia
+++
Essentials of Diagnosis
++
+++
General Considerations
++
Cause is unknown, but it is likely a multifactorial, two-stage process
The first stage: probable disturbance in placental implantation involving the spiral arteries very early in gestation; the abnormal placental perfusion that results leads to the formation of noxious free radicals
The second stage: excessive inflammation causing endothelial damage, vasospasm, and finally clinical signs and symptoms
An immunologic component has been proposed, citing the increased incidence in primigravidas
This entire process is likely enhanced by environmental factors, genetic predisposition, and preexisting maternal disease
Can occur any time after 20 weeks' gestation and up to 6 weeks' postpartum
The only cure is delivery of the fetus and placenta
Uncontrolled eclampsia is a significant cause of maternal death
5% of women with preeclampsia progress to eclampsia
++
++
See Table 19–3
Preeclampsia without severe features
Patients usually have few complaints
Diastolic blood pressure < 110 mm Hg
Edema may be present
Platelet count ≥ 100,000/mcL (100 × 109/L)
Antepartum fetal testing is reassuring
CNS irritability is minimal
Epigastric pain is not present
Liver enzymes are not elevated
Proteinuria is present with urine protein ≥ 0.3/24 hours
Preeclampsia with severe features
Patients may complain of headache and changes in vision
Blood pressure often ≥ 160/110 mm Hg
Proteinuria may not always be present
Thrombocytopenia (platelet counts < 100,000/mcL [100 × 109/L]) may be present and progress to disseminated intravascular coagulation
Severe epigastric pain may be present from hepatic subcapsular hemorrhage with significant stretch or rupture of the liver capsule
HELLP syndrome is a form of severe preeclampsia
Severity can be assessed ...